An Explainable AI-Guided Framework for Cancer Pain Phenotyping and Clinical Decision-Making

Purpose Current pain management often relies primarily on pain intensity, which may not capture patient variability or guide individualized care. Advances in machine learning (ML) and explainable artificial intelligence (XAI) offer opportunities to improve assessment by identifying clinically meaningful subgroups and enhancing model interpretability. This study aimed to identify distinct cancer pain phenotypes using explainable machine learning and to develop a phenotype-guided clinical decision framework to sup…

By the Truvace deskOctober 16, 20262 min read1 sourcePeer-reviewedTRV-2026-1618· cite & verify

In brief

Researchers analyzed data from 260 cancer patients with machine learning to group them by pain profile rather than by pain intensity alone. The analysis produced four phenotypes: High-Burden Pain, Catastrophizing-Dominant, Stress-Related Pain, and Low-Risk Adaptive. Of three boosting models tested, CatBoost performed best.

The work matters because pain care that relies mainly on intensity scores may miss differences between patients that call for different treatments. The authors propose that psychological and behavioral factors be included in routine assessment. Whether this improves patient outcomes was not tested in the cross-sectional design, so that benefit remains a hypothesis.

Main points

The study used a cross-sectional design with data from 260 cancer patients.
Inputs included pain intensity, catastrophizing, psychological distress, quality of life, and self-management strategies.
CatBoost reached accuracy of 0.98 and an F1 score of 0.97, the best of the three models compared.
SHAP and LIME analyses pointed to cognitive and emotional factors as the main drivers of classification.
A phenotype-guided decision framework was developed to align patient profiles with targeted interventions.

The gain

In 260 cancer patients, explainable ML identified four pain phenotypes and showed that catastrophizing and distress predicted group membership more than pain intensity, supporting a framework for individualized care.

The rundown

The authors start from the concern that current pain management often relies primarily on pain intensity, which may not capture patient variability or guide individualized care. They applied machine learning to find clinically meaningful subgroups.

Three models, XGBoost, LightGBM and CatBoost, were compared on accuracy, precision, recall and F1 score. Two explainability methods, SHAP and LIME, were applied to make the classification transparent and identify key predictors.

From the phenotypes, the team built a clinical decision framework matching patient profiles to targeted interventions. They conclude that this supports personalized, mechanism-based pain management and may help clinicians recognize subgroups with different treatment needs.